A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)

NCT04093752 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

917

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Tirzepatide
DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company